According to TipRanks, Goldwasser is a 5-star analyst with an average return of 13.7% and a 65.31% success rate. Goldwasser covers the Healthcare sector, focusing on stocks such as Humana, AmerisourceBergen, and Cardinal Health.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Humana with a $556.56 average price target, a -0.27% downside from current levels. In a report released on October 26, Deutsche Bank also upgraded the stock to a Buy with a $576.00 price target.
The company has a one-year high of $563.13 and a one-year low of $349.41. Currently, Humana has an average volume of 835.4K.
Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HUM in relation to earlier this year. Last month, Timothy Huval, the CAO of HUM sold 7,437.00 shares for a total of $3,759,403.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Humana Inc. is a leading health insurance service provider in the United States. The company, through its Retail division, provides medicare benefits and state-based medicaid contracts, which are marketed on a retail basis to individuals. The Group and Specialty business offers employer group commercial fully-insured medical products and specialty health insurance benefits. Humana offers pharmacy solutions, provider services, home-based services, and clinical programs to the company’s health plan members as well as to third parties through the Healthcare Services segment.
Read More on HUM: